pe pagina
  • 80.00 lei

    In 1962, Leonard Hayflick created and then froze roughly 800 tiny ampules of what he dubbed WI-38 cells. Each petite glass vial contained between 1.5 million and 2 million cells. Each cell in each vial, once thawed, had the capacity to divide another 40 times. Hayflick had created a supply of cells that, for practical purposes, was almost infinite.
    Hayflick’s WI-38 cells would become the first normal, non-cancerous cells available in virtually unlimited quantities to scientists, and, as a result, the best-characterized normal cells available to this day. They would become the basis for vaccines that have immunized hundreds of millions of people worldwide against polio, rubella, rabies, chicken pox, and measles. Today approximately two billion people have directly benefitted from the use of WI-38 and other cell strains created using Hayflick’s methods.WI-38 would also spawn a lifetime feud between Hayflick and his superiors at the Wistar, and an epochal fight with the US government, first over whether the cells were safe to use to make vaccines and then over who owned them.
    The Cells and the Scientist combines scientific discovery, rivalry, greed and drama; abortion and vaccine politics; and timely questions about the tradeoff between socially beneficial medical research and the rights of individuals. Remarkably, both Leonard Hayflick and the 83-year-old mother of the fetus that gave rise to WI-38 are still alive. The mother lives near Stockholm. She was not asked permission for the use of her fetus and has never earned a penny from the contribution.
    The tale of WI-38 is a profoundly human one, laced with real effects on untold numbers of lives. Consider this irony: cells derived from an aborted fetus have prevented tens of millions of miscarriages that otherwise would have been caused by the rubella virus, which infects foetuses in the womb.

  • 115.00 lei

    The physician and botanist William Woodville (1752–1805), a proponent of inoculation against smallpox, was in 1791 appointed physician to the London Smallpox and Inoculation Hospital. Five years later, Edward Jenner announced his experiments with vaccination - inoculation with the much milder cowpox, which conveyed immunity to smallpox without the attendant risk of catching the often fatal disease. Woodville eagerly pursued trials using vaccination, and published the results in this 1799 work, which describes two hundred cases where patients (usually children) were vaccinated with matter obtained from either cows or other cowpox sufferers, and supplies a table of the patterns of infection from person to person. Most of these patients were later tested by inoculation with smallpox, and none caught the disease. This demonstration of the safety and efficacy of vaccination led to its much wider adoption, to which Woodville gave practical support in both England and France.

  • Ebola: An Evolving Story
    La comanda in aproximativ 4 saptamani
    115.00 lei

    The book is a narrative of the unfolding of the Ebola virus disease outbreak from a scientific view point. The author provides an analysis of the scientific basis of public health policies that have influenced the public's, and the medical community's, abilities to understand the virus and the disease. This is done in the context of providing insights into the biology of the virus, and exploring open questions, including its likely modes of transmission. The author has included citations from the scientific literature and the press, as well as quotes from expert interviews. The book will help sort out the fact from fiction, given the confusion that arose after the virus arrived in the US. The author used his objective research skills and knowledge of evolutionary genetics and molecular biology to find out what was known, and what questions remained unanswered, and even what questions remained unasked.Written in an accessible style, it is intended for the educated general public, scientists, policy makers, health care workers, and politicians. It delves into the problems of trying to derive a logic-based understanding of a highly lethal emerging disease in 2014, when research funding cuts have gutted research institutions, and when public health institutions really were woefully unprepared. It is a highly distinct narrative analysis that is sure to stimulate new research and thinking in public policy. It will inform thousands of people of the nature of the virus, how it works, in terms they are likely to be able to understand. It will allow others to rapidly catch up with the story of Ebola.

  • Maladies Infectieuses ECN Programme 2016
    La comanda in aproximativ 4 saptamani
    117.00 lei

  • Cerebro-Spinal Fever
    La comanda in aproximativ 4 saptamani
    144.00 lei

    In 1915, an outbreak of meningitis affected the Eastern Command in the British Army. Foster and Gaskell, both Captains in the Royal Army Medical Corps in the Territorial Army, were on hand to witness the effect of the disease, and the following year they published this study of the disease's symptoms and treatment as they observed it. The text is accompanied by plates illustrating meningitis' effects on the skin and brain. This book will be of value to anyone with an interest in the history of epidemiology and the treatment of meningitis.

  • 151.00 lei

    Originally published in 1915, this book gathers together a collection of papers on tuberculosis by the renowned British epidemiologist Arthur Ransome (1834–1922). The papers approach the subject from a number of different viewpoints, encompassing both scientific and public health perspectives, and draw on Ransome's experience of more than fifty years fighting tuberculosis. Illustrative figures and notes are also incorporated within the text. This book will be of value to anyone with an interest in tuberculosis and the history of medicine.

  • 151.00 lei

    First published in 1903, this book presents a wide-ranging study of rabies. Three key areas of the disease are explored: its causation in the individual organism, its place among germ diseases with the end of bacterial agency in the animal economy, and its origin in the animal kingdom. This book will be of value to anyone with an interest in epidemiology and the historical understanding of rabies.

  • 156.00 lei

    Nelson's Neonatal Antimicrobial Therapy is your go-to reference for treating neonates with infectious diseases. This handy reference provides evidence-based recommendations from leading experts in antimicrobial therapy for the treatment of infectious diseases in neonates. Get expert advice on: Dosing for neonates, including low-birth-weight newborns Drug selection for bacterial, fungal, viral and parasitic pathogens Drug Stewardship And more

  • 158.00 lei

    An army surgeon and later deputy inspector of hospitals in Jamaica, James Dillon Tully (1785–1827) witnessed at first hand the spread of the plague through the Mediterranean in the early nineteenth century. In particular, he was instrumental in controlling the disease in Corfu and Cephalonia. This work, first published in 1821, is his account of the outbreak and the response to it after its arrival by ship in Malta. Tully's goal in writing the book was to educate the public about the plague, in response to doubts over the nature of this recent outbreak. He focuses on describing the disease, the manner by which it spread, and methods of treating and controlling it. Stressing the historical effectiveness of quarantine and spelling out its implementation in the Mediterranean, this work is a detailed and methodical source which remains of interest to researchers in the history of medicine and epidemiology.

  • 160.00 lei

    Covers four of the major strands of the courses taught to medical undergraduates under the umbrella terms of epidemiology and public health.

  • 194.00 lei

    Originally published in 1917, as part of the Cambridge Public Health Series, this book was written to provide a guide for those 'interested in the stamping out of tuberculosis'. The text approaches the disease from an outlook based around experimental pathology, avoiding the clinical perspective already well represented in previous works by other researchers. Numerous illustrative figures and an appendices section are also included. This book will be of value to anyone with an interest in public health, the history of medicine and the historical understanding of tuberculosis.

  • 194.00 lei

    In this first volume of his history of epidemics in Britain, controversial physician Charles Creighton begins his examination of diseases in Britain from the first British epidemic in 664 AD to the end of the Great Plague in 1666. The work is broken down by time period and disease, ranging from Bede's record of the plague of 664–684 to 'the French pox', as well as outbreaks during sea voyages and in the early colonies. This work will be of value to medical historians and those with an interest in epidemiology.

  • 201.00 lei

    In this second volume of his history of epidemics in Britain, controversial physician Charles Creighton continues his examination of diseases in Britain from the time of Charles II to the time of the volume's publication in 1894. The work is broken down by disease, ranging from typhus to childhood diseases, as well as examining the origin and consequences of specific outbreaks in the United Kingdom, Ireland and among British troops abroad. This work will be of value to medical historians and those with an interest in epidemiology.

  • 207.00 lei

     

    • Concise pocketbook designed to support physicians, virologists, and immunologists in their day-to-day practice
    • Written and edited by key thought leaders and developed using the latest clinical evidence and guidelines
    • High quality full-color supportive illustrations, tables and graphs enable complicated concepts to be made clear to readers with different levels of background understanding

    About this book

    This concise pocketbook will provide readers with an overview and background of meningococcal disease, treatment options and emerging therapies, and methods of prevention. The book was originally commissioned due to recent developments in vaccinations to prevent meningococcal disease.

    This book reviews the disease progression and associated risk factors; its pathogenesis and diagnosis; methods of treatment and prevention, both current and emerging; and the future directions of meningococcal disease management. The book is ideal for busy healthcare professionals, as it covers all aspects of the disease and its treatment in a condensed and manageable format, whilst including the most up-to-date treatment guidelines and algorithms.

     

    Table of contents (7 chapters)

     

    ·         Introduction and epidemiology of meningococcal disease

    Trotter, Caroline (et al.)

    Pages 1-14

    ·         Carriage and transmission of

    Trotter, Caroline L. (et al.)

    Pages 15-23

    ·         Pathogenesis of invasive disease

    Øvstebo, Reidun (et al.)

    Pages 25-43

    ·         Diagnosis of meningococcal disease

    Tsang, Raymond (et al.)

    Pages 45-55

    ·         Clinical aspects of meningococcal disease

    Pelton, Stephen (et al.)

    Pages 57-73

    ·         Treatment of meningococcal disease

    Nadel, Simon (et al.)

    Pages 75-90

    ·         Prevention of meningococcal disease through vaccination

    Pollard, Andrew J. (et al.)

    Pages 91-103

  • 209.00 lei

    This book has been described as a 'watershed work [which] has probably not received the credit it deserves'. Its author, John Pringle (1707–82), gained his experience of military medicine as physician to Lord Stair, the commander of the British army in Europe. The duke of Cumberland later promoted him to physician-general, and he served in the army until 1748. His 'observations' were published in 1752, and were immediately successful: this revised second edition was published in 1753, and many further editions followed. Pringle became acutely aware that the field and permanent hospitals designed to treat wounded soldiers were in fact a large part of the problem of sickness and death, since contagious diseases spread rapidly among weakened men in unhygienic surroundings. He made practical suggestions to improve hygiene and isolate the sick, but unfortunately his often simple proposals were ignored by the army high command for almost a century.

  • 215.00 lei

    Fully reviewed and revised for its second edition, the Oxford Handbook of Infectious Diseases and Microbiology maintains its position as the must-have guide to all aspects of infectious diseases and microbiology. Reflecting the current approach to joint postgraduate training programmes, the handbook takes an integrated approach to both subjects. It covers the basic principles of bacteriology and virology, along with specific guidance on individual diseases and conditions, all in the accessible Oxford Handbook style.

    Now including new topics on important subjects such as microbiology specimen collection, commonly used media, molecular diagnostics, and antimicrobials in pregnancy, as well as incorporating new guidelines from WHO, NICE, and BASHH among others, this handbook ensures that the informaiton you need is accessible, clear, and easy-to-understand.

    Practical and comprehensive, this handbook includes coverage of National Frameworks and current legislation, together with information on topical issues such as bioterrorism and preventative medicine. Fully reviewed by specialist senior readers, and with useful links to up-to-date clinical information and online resources, this is an important addition to the Oxford Handbook Series.


  • 40000lei 285.00 lei

     Transplant and oncology patients present a challenge to the infectious disease specialist because many of the entities that infect them are hard to diagnose.  Chemotherapy may further complicate the situation, since it may contraindicate a biopsy or interfere with antibiotic therapy. This issue of Infectious Disease Clinics provides specific information on several entities with the purpose of helping physicians to best treat these difficult infections.

  • Evidence-Based Neonatal Infections
    La comanda in aproximativ 4 saptamani
    33100lei 290.00 lei

    Evidence-Based Neonatal Infections is expertly written by David Isaacs, an experienced author renowned for his knowledge in both pediatric infections and evidence-based medicine. It critically analyses the evidence for decision making in neonatal infections. Evidence-Based Neonatal Infections * The first evidence-based text on neonatal infections * Provides practical guidance where evidence is poor * Complements David Isaacs Evidence-Based Pediatric Infectious Diseases (9781405148580) Practical and evidence-based, Evidence-Based Neonatal Infections is designed to help the clinician with day-to-day decisions on the care of newborn babies with possible, probable or proven infections. It considers clinical questions relevant to neonatologists, analysing the evidence carefully and providing recommendations for optimum management of neonatal infectious diseases, whilst reflecting on: * Efficacy and safety * Antibiotic resistance * Cost effectiveness * Adverse effects * Ethical considerations Evidence-Based Neonatal Infections provides a unique reference for neonatologists, pediatricians, trainees, specialist nurses; general practitioners, microbiologists, infection control doctors, and all staff in neonatal units.

  • 37500lei 340.00 lei

    CONGENITAL AND PERINATAL INFECTIONS provides a concise and clinically-oriented primer on the congenital and perinatal infections likely to present in clinical practice. Written with the busy clinician in mind, it combines easy accessibility with state-of-the-art information on the epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention of congenital and perinatal infections.

    Eschewing the notion that congenital and perinatal infections only encompass agents from the TORCH group of pathogens, this volume offers comprehensive information on the spectrum of viral, bacterial, and parasitic infections that can manifest in mother or child. Combined with its brevity and emphasis on clinical management, CONGENITAL AND PERINATAL INFECTIONS is a definitive new guide to understanding this challenging group of infections.

  • 46200lei 370.00 lei

    Written by an international team of authors specializing in microbiology and infectious disease, this new edition of Evidenced-based Infectious Diseases presents practical, up-to-date information on the care of individual patients suffering from infectious diseases. Each chapter addresses a series of focused clinical questions addressed in a systematic fashion, including a comprehensive literature search, and a rating of the quality of evidence using principles of the GRADE framework. Evidence-Based Infectious Diseases is the ideal reference work for all those involved with microbiology, infectious diseases, and clinical management. 

    Table of contents

    List of Contributors vii

    Preface xi

    1 Introduction to Evidence‐based Infectious Diseases 1

    Dominik Mertz, Nick Daneman, and Fiona Smaill

    Part 1 Specific Diseases 11

    2 Skin and Soft‐tissue Infections 13

    Douglas Austgarden and Guilio DiDiodato

    3 Bone and Joint Infections 23

    Nora Renz and Andrej Trampuz

    4 Infective Endocarditis 37

    Bahareh Ghadaki and Deborah Yamamura

    5 Meningitis and Encephalitis 53

    Christopher E. Kandel and Wayne L. Gold

    6 Community‐acquired Pneumonia 73

    Mark Downing and Jennie Johnstone

    7 Healthcare‐associated Pneumonia 81

    Jennie Johnstone and Mark Downing

    8 Tuberculosis 87

    Peter Daley and Marek Smieja

    9 Clostridium Difficile Infection in Adults 99

    Louis Valiquette

    10 Urinary Tract Infections 107

    Thomas Fekete

    11 Sexually Transmitted Infections 127

    Courtney A. Thompson, Darrell H. S. Tan, and Kaede Sullivan

    12 Human Immunodeficiency Virus (HIV) 149

    Ali Amini, Monique Andersson, Ravindra Gupta, and Brian Angus

    13 Hepatitis 181

    Lise Bondy and Michael S. Silverman

    14 Influenza 193

    Ashley Roberts and Joanne M. Langley

    15 Critical Care 201

    Bram Rochwerg and Jocelyn A. Srigley

    Part 2 Special Populations 215

    16 Infection Prevention and Control 217

    Graham M. Snyder and Eli N. Perencevich

    17 Antimicrobial Stewardship 235

    Alainna J. Jamal and Andrew M. Morris

    18 Infections in Neutropenic Hosts 251

    Eric J. Bow

    19 Infections in General Surgery 269

    Paul A. Moroz and Christine H. Lee

    20 Infections in Healthcare Workers 279

    Gregory W. Rose

    Index 287

  • 53100lei 475.00 lei

    This volume serves as a reference for the dissemination of advances made in the study of Hepatitis B Virus (HBV). Hepatitis B Virus: Methods and Protocols details protocols and techniques ranging from cell culture studies to in vivo and clinical immunology. The chapters in this book discuss treatments of in vitro infection systems, analysis and quantification of cccDNA and its mutations; in vitro polymerase activity assays; cellular trafficking of core proteins; intracellular calcium metabolism; detection, cloning, and sequencing of HBV markers; and new strategies aimed at exploiting new mechanisms for drug discovery. The book also covers classical methods for resolution of extracellular viral particles by native gel electrophoresis, and methods for detecting HBV antigens in drug discovery. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

    Cutting-edge and comprehensive, Hepatitis B Virus: Methods and Protocols is a valuable tool for researchers to use toward their advanced studies in HBV.

  • 53100lei 475.00 lei

    This book introduces readers to Direct Acting Antiviral (DAAs) agents, newly developed drugs to treat chronic hepatitis C virus infection, which have an excellent anti-viral effect on virus replication. These drugs have been developed to enhance the effect of interferon and ribavirin, as the resistant strains against each drug have been described both in vitro and in vivo and the existences of naturally occurring variants have been reported. However, since the combination of different classes of DAAs is sufficient to completely eradicate the virus without the need for interferon or ribavirin, the current treatment regimen does not include interferon. Ribavirin is used in combination with sofosbuvir, a potent polymerase inhibitor, to enhance its antiviral effects.

    Hepatitis C Virus Treatment offers readers a comprehensive guide to hepatitis C; describing the resistance profiles against these drugs and shedding light on the difficulties involved in DAA therapy and the direction of future treatments, it will equip doctors to understand the essentials of treating the disease. It also describes in detail new and innovative DAA treatments, the effects of the agents, and the characteristics of resistance, providing cutting-edge information not only for hepatologists, but also for researchers, clinical residents, and medical students.

  • 480.00 lei

    Written by an international, interdisciplinary team of physicians, veterinarians, virologists, medical microbiologists, and parasitologists, Zoonoses: Infectious Diseases Transmissible from Animals to Humans covers zoonotic pathogens as agents of emergence and reemergence of zoonotic diseases, opportunistic zoonotic infections, risks of iatrogenic transmission and xenotransplantation, imported zoonotic infections, food-borne zoonoses, transmissible spongiform encephalopathies, and of warfare. Zoonoses is a valuable physician's reference that covers all aspects of epidemiology, diagnosis and differential diagnosis as well as therapy and prophylaxis of zoonotic diseases caused by bacteria, viruses, parasites, and fungi. Today, more than 200 diseases occurring in humans and animals are known to be mutually transmitted. Classic infectious diseases such as rabies, plague, and yellow fever have not been eradicated despite major efforts. New zoonotic diseases are appearing due to global conditions such as overpopulation, wars, and food scarcity, which facilitate human contact with rodents, stray animals, and their parasites. In addition, humans are unwittingly becoming accidental hosts and new links in an infectious chain by engaging in activities such as survival training, which involves camping in open areas, and consumption of raw or insufficiently cooked food. Zoonotic infections cause a variety of symptoms that often do not provide clear evidence of a known disease. Zoonoses, Fourth Edition, describes most occurring worldwide zoonoses and facilitates the identification, diagnosis, and treatment of zoonotic infections. Written by a team of doctors, medical microbiologists and veterinarians, this revised and updated edition—translated from the noted German reference Zoonosen—covers all aspects of the epidemiology and prevention of zoonotic diseases supported by clear descriptions of various illnesses. Specifically, this fourth edition covers zoonoses caused by: • Viruses, bacteria, fungi, and parasites • infections caused by animal bites • infections and intoxications by animal foods • iatrogenic transmission of zoonotic pathogens

  • 60500lei 510.00 lei

    There are approximately 4 million newborns annually in the United States, including 400,000 infants born preterm.  This care occurs in nurseries of all acuity levels, sizes, and regions across the country and is provided by a variety of providers, including pediatricians, family practice doctors, nurse practitioners, and physician assistants.  The most common complication during the newborn period is suspected or proven infection – either those acquired during the delivery itself or before delivery in the womb.  Indeed, 4 of the 8 most commonly-prescribed medications in newborns annually are antibiotics. Therefore, these providers must all be knowledgeable about the clinical presentation, epidemiology, and approach to diagnosis, treatment and prevention of neonatal infections.  However, many of these nurseries do not have convenient access to pediatric infectious disease consultation or support, and would benefit from a convenient reference guide.

    This book effectively and succinctly covers the pathophysiology, epidemiology, clinical presentation, approach to diagnosis and treatment, and important aspects of preventative care for the most frequently encountered neonatal and congenital infections.  The first section discusses common neonatal infections (i.e., those acquired during or after delivery), including sepsis, meningitis, pneumonia, and other focal infections.  The second section covers the most frequently encountered congenital infections (i.e., those acquired via the placenta while the fetus is still in-utero).  Finally, the concluding section discusses the basics of infection prevention in the nursery setting, including general principles of infection prevention, how to apply those principles to families, and how to manage a suspected outbreak of infection within a nursery.

    This book is a unique contribution to the field. Existing texts such as the AAP Red Book fold neonatal infections in within chapters on a given pathogen, but the information is difficult to find and access quickly.  By covering neonatal and congenital infections thoroughly while still keeping each section clear and concise, this Handbook will be a valuable resource for the busy nursery provider.

  • 515.00 lei

    Vulvovaginal Infections presents new knowledge to help clinicians accurately diagnose and treat their patients and highlights for researchers remaining unsolved problems and the most promising areas for continued investigation. Clinical gynecologists will find practical advice and extensive insight into solving real-life clinical scenarios. The book opens by presenting information on the microbiology of the vagina and vaginal immunology. It then discusses the diagnosis of vulvovaginal disease, including physical examination, screening processes, and laboratory testing. Diagnosis is followed by covering various vulvovaginal infections including bacterial vaginosis, Candida vulvovaginitis, Trichomonas vaginalis vaginitis, genital herpes, human papillomavirus genital infections, allergic vulvovaginitis, menopausal vulvovaginitis, cytolytic vaginosis, aerobic vaginitis, and more. For each of these conditions, the book presents information on its background, microbiology, immunology, prevention, diagnosis, and treatment. Therapy details are provided with an emphasis on nuances that can be applied to women who fail to respond to medication prescribed or who respond and then become symptomatic once treatment has ended. This new edition discusses major advances in the characterization of endogenous microbiota that populate the genital tract in women of all ages. It also provides a more sophisticated appreciation of immune mechanisms found in the healthy female genital tract and alterations that increase both susceptibility and consequences of various infectious and noninfectious disorders. A major impetus for writing this new edition is to help the busy clinician, resident, or fellow by explaining advances in individual disorders in a manner that is relevant to their practice.

  • 570.00 lei

    Editor in Chief: W. David Hardy and Compiled by American Academy of HIV Medicine

    • The authoritative and up-to-date reference work on the clinical care of HIV/AIDS, authored by more than 50 expert clinicians in immunology, HIV epidemiology, gerontology, substance abuse treatment, infectious disease medicine, and other fields central to its medical management
    • Topic-based chapters on all aspects of clinical care and proficiency, including: epidemiology and prevention; basic science; clinical management; social, economic, and population factors; and clinical research
    • Extensive information on the treatment challenges and recommendations for managing co-infection and co-morbidities
    • Appropriate for both physicians and a wide range of non-physician health professionals, including dentists, nurses, pharmacists, and workers outside clinical settings

    Completely updated for 2017, Fundamentals of HIV Medicine is a comprehensive clinical care publication for the treatment of HIV/AIDS. Published by the American Academy of HIV Medicine, the book offers physicians, pharmacists, nurse practitioners, and other care providers the most up-to-date overview of the latest HIV treatments and guidelines plus online access to CME.

    Embodying the AAHIVM's commitment to promoting uniform excellence in care of seropositive patients, Fundamentals of HIV Medicine 2017 empowers health professionals to deliver standardized, life-sustaining treatment to the patients who need it most. It will serve as an essential clinical reference and provide valuable career enrichment to users across the spectrum of HIV care, treatment, and prevention.

    Table of Contents

    1. Epidemiology and the Spread of HIV
    2. The Origin, Evolution, and Epidemiology of HIV-1 and HIV-2
    3. Mechanisms of HIV Transmission
    4. HIV Transmission Prevention
    5. Immunology
    6. HIV Cure Strategies
    7. HIV Testing and Counseling
    8. Laboratory Testing Strategies: Detection and Diagnosis
    9. The Medical History and Physical Examination of the HIV-Infected Patient
    10. Initial Laboratory Evaluation and Risk Stratification of the HIV-Infected Patient
    11: Clinical Syndromes and Differential Diagnosis in the HIV-Infected Patient
    12. Health Maintenance
    13. Issues in Specific Patient Populations
    14. Complementary and Alternative Medicine CAM/Integrative Medicine Approaches
    15. Care Coordination
    16. Palliative Care and End-of-Life Support
    17. HIV Virology
    18. Principles of Applied Clinical Pharmacokinetics and Pharmacodynamics in Antiretroviral Therapy
    19. Classes of Antiretrovirals
    20. Initiations of Antiretroviral Therapy: What to Start with
    21. HIV-1 Resistance to ARVS
    22. Managing the Patient with Multi-Drug Resistant HIV
    23. Future Antiretrovirals, Immune-Based Strategies, Therapeutic Vaccines
    24. The Pharmacist's Role in Caring for HIV Positive Individuals
    25. Solid Organ Transplantation in HIV-Infected Individuals
    26. Antiretroviral Therapy in Pregnant Women
    27. Antiretroviral Therapy of Children and Newborns
    28. Immunosuppressants and Antiretroviral Therapy in HIV-Positive Transplant Patients
    29. Understanding and Managing Antineoplastic and Antiretroviral Therapy
    30. Substance Abuse in HIV Populations
    31. Understanding the Use of Antiretrovirals in the Aging Patient
    32. Opportunistic Infections
    33. Malignant Diseases in HIV
    34. Dermatologic Complications
    35. Endocrine Disorders
    36. Non-Opportunistic Infections: Respiratory Complications
    37. Psychiatric Illness and Treatment in HIV Populations
    38. HIV Associated Neurocognitive Disorders
    39. HIV/Hepatitis Co-Infection HIV and Hepatitis B Co-Infection
    40. Ocular Complications
    41. Cardiovascular Disease
    42. Renal Complications
    43. Musculoskeletal Complications of HIV
    44. Sexually Transmitted Diseases
    45. HIV and Bone Health
    46. HIV Associated Lipodystrophy and Lipoatrophy
    47. Dyslipdidemia
    48. Immune Reconstitution Inflammatory Syndrome (IRIS)
    49. US Healthcare Systems, HIV Programs, and Coverage Policy Issues
    50. Legal Issues
    51. Research Design and Analysis
    52. Ethical Conduct of Clinical Trials, Institutional Review Boards, Informed Consents and Financial Conflicts of Interest

  • 72100lei 650.00 lei

    The Oxford Textbook of Medical Mycology is a comprehensive reference text which brings together the science and medicine of human fungal disease. Written by a leading group of international authors to bring a global expertise, it is divided into sections that deal with the principles of mycology, the organisms, a systems-based approach to management, fungal disease in specific patient groups, diagnosis, and treatment.

    The detailed clinical chapters take account of recent international guidelines on the management of fungal disease. With chapters covering recent developments in taxonomy, fungal genetics and other "omics", epidemiology, pathogenesis, and immunology, this textbook is well suited to aid both scientists and clinicians.

    The extensive illustrations, tables, and in-depth coverage of topics, including discussion of the non-infective aspects of allergic and toxin mediated fungal disease, are designed to aid the understanding of mechanisms and pathology, and extend the usual approach to fungal disease.

    This textbook is essential reading for microbiologists, research scientists, infectious diseases clinicians, respiratory physicians, and those managing immunocompromised patients. Part of the Oxford Textbook in Infectious Disease and Microbiology series, it is also a useful companion text for students and trainees looking to supplement mycology courses and microbiology training.

  • Infectious Diseases and Nanomedicine II
    La comanda in aproximativ 4 saptamani
    702.00 lei

    The book addresses the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences. The book is a second volume which presents collection of best papers presented in the First International Conference on Infectious Diseases and Nanomedicine held during Dec. 15-18, 2012 in Kathmandu, Nepal.

  • Infectious Diseases and Nanomedicine I
    La comanda in aproximativ 4 saptamani
    702.00 lei

    The book addresses the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences. The book is a first volume which presents collection of best papers presented in the First International Conference on Infectious Diseases and Nanomedicine held during Dec. 15-18, 2012 in Kathmandu, Nepal.

  • 78600lei 705.00 lei

    Description

    The fourth edition of this best-selling Red Book® image companion aids in the diagnosis and treatment of more than 160 of the most commonly seen pediatric infectious diseases. This edition features Zika virus, chikungunya, serious bacterial infections caused by Enterobacteriaceae, Moraxella catarrhalis, human parechovirus, rhinovirus, staphylococcal food poisoning, Staphylococcus aureus, coagulase-negative staphylococcal infections, Ureaplasma urealyticum, and Ureaplasma parvum.

     

    Streamline disease recognition and clinical decision-making with hundreds of finely detailed color images, combined with updated step-by-step guidelines.

     

    Concise text descriptions walk the reader through the diagnosis, evaluation, and management essentials for each condition.

     

    • Clinical manifestations
    • Epidemiology
    • Diagnostic tests
    • Etiology
    • Incubation period
    • Treatment

     

    Contents include:

    • Adenovirus Infections
    • Bacteroides and Prevotella Infections
    • Candidiasis
    • Cystosporiasis (formerly Isosporiasis)
    • Epstein-Barr Virus Infections (Infectious Mononucleosis)
    • Human Herpesvirus 6 (including Roseola) and 7
    • Lyme Disease (Lyme borreliosis, Borrelia burgdorferi Infection)
    • Meningococcal Infections
    • Human Papillomaviruses
    • Pelvic inflammatory disease
    • Pneumococcal Infections
    • Respiratory Syncytial Virus
    • Group A Streptococcal Infections
    • Staphylococcus aureus
    • Plus much more...

  • 84500lei 745.00 lei

    Description: Diagnostic Pathology: Infectious Diseases takes a comprehensive look at infectious diseases, their anatomic manifestations, and how to ensure a complete and accurate sign out at the microscope. A user-friendly chapter landscape and thousands of high-quality images combine to make this medical reference book a key companion for the general surgical pathologist or resident in training.
    Features:
    • Comprehensive discussions on how to sign out cases.
    • Formatted into sections by organism type (Virus, Bacteria, Fungi, and Parasite), and further divided by those that can be diagnosed on histological appearance.
    • Species-specific pathologies for finding "zebra" cases.
    • Essential information is listed in a bulleted format with numerous high-quality images to facilitate learning.
    • "Key Facts" highlight the quick criteria needed for diagnosis or adequacy evaluation at the time of a procedure.
    • Features clear pictures of diagnostic forms, ancillary diagnostic tools, including microbiology and molecular diagnostics, pathological reaction patterns expected for given organisms, and important common and uncommon pathogens.
    • Explains when and when not to use molecular diagnostics, and discusses histological limitations and how to address them at sign out.
    • Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.

  • 97300lei 775.00 lei

    Description:
    Regarded as the definitive source of information in the field, Infectious Diseases of the Fetus and Newborn Infant remains your indispensable source for authoritative, state-of-the-art answers. Edited by Drs. Wilson, Nizet, Maldonado, Remington, and Klein, this fully updated reference helps you apply the latest evidence-based recommendations in the prevention, diagnosis, and management of infections found in utero, during delivery, and in the neonatal period in both premature and term infants.

    Features:
    • Form a definitive diagnosis and create the best treatment plans possible using evidence-based recommendations and expert guidance from world authorities.
    • Locate key content easily and identify clinical conditions quickly thanks to a consistent, highly user-friendly format now featuring a full-color design with hundreds of illustrations, and fresh perspectives from six new authoritative chapter lead authors.
    New To This Edition:
    • Explore what’s changing in key areas such as: - emerging problems and concepts in maternal, fetal, and neonatal infectious diseases - anticipation and recognition of infections occurring in utero, during delivery, and in the neonatal period
    • Stay on the cutting edge of your field with new and improved chapters including: obstetric factors associated with infections of the fetus and newborn infant; human milk; borella infections; tuberculosis; bordetella pertussis and other bordetella sp infections; herpes simplex; toxoplasmosis; pneumocystis and other less common fungal infections; and healthcare-associated infections in the nursery
    • Keep up with the most relevant topics in fetal/neonatal infectious disease including new antimicrobial agents, gram- negative infections and their management, and recommendations for immunization of the fetus/mother.
    • Overcome clinical challenges in developing countries where access to proper medical care is limited.
    • Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.

  • 1,22900lei 1050.00 lei

    Trusted by physicians and advanced practice providers through ten standard-setting editions, Fanaroff and Martin's Neonatal-Perinatal Medicine, 11th Edition, remains the reference of choice for expert, multidisciplinary guidance on the management and evidence-based treatment of problems in the mother, fetus, and neonate. An expanded team of international authors, led by Drs. Richard J. Martin, Avroy A. Fanaroff, and Michele C. Walsh of Rainbow Babies and Children's Hospital, brings you up to date with advances in the control of nosocomial infections in preterm infants, genetic disorders and birth defects, the fetal origins of adult disease, the late preterm infants, and much more - all designed to help you improve the quality of life and long-term outcomes of your patients. Helps you make informed clinical choices for each patient - from diagnosis and treatment selection through post-treatment strategies and management of complications - with a dual focus on neonatology and perinatology. Includes a new chapter on Social and Economic Contributors to Neonatal Outcome. Features extensive updates and reorganization throughout, with new Key Points at the end of each chapter Provides up-to-date, evidence-based content, with more information on precision medicine and genetics. Uses detailed, full-color illustrations that depict disorders in the clinical setting and explain complex information. Offers indexing in both volumes that provides quick access to specific guidance. Remains the most comprehensive, multidisciplinary text in the field - an excellent source of information for every stage of your practice. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

  • 1,28500lei 1160.00 lei

    Drs. Cohen, Powderly and Opal, three of the most-respected names in infectious disease medicine, lead a diverse team of international contributors to bring you the latest knowledge and best practices. Extensively updated, the fourth edition includes brand-new information on advances in diagnosis of infection; Hepatitis C; managing resistant bacterial infections; and many other timely topics. An abundance of photographs and illustrations; a practical, clinically-focused style; highly-templated organization; and robust interactive content combine to make this clinician-friendly resource the fastest and best place to find all of the authoritative, current information you need.

    New to this edition
    • Sweeping updates include new or revised chapters on:
      •  

      • Hepatitis C and antivirals
      •  

         

      • Fungal infection and newer antifungals
      •  

         

      • Microbiome and infectious diseases as well as advances in diagnosis of infection; Clostridium difficile epidemiology; infection control in the ICU setting; Chlamydia trachomatis infection; acquired syndromes associated with autoantibodies to cytokines;; management of multidrug resistant pathogens; probiotics, polymyxins, and the pathway to developing new antibiotics
      •  

         

      • HIV including HIV and aging, antiretroviral therapy in developing countries, and cure for HIV.

       

       

    • Online Antimicrobial pharmacokinetics mannequin, as well an all new HIV medicine mannequin are a useful visual source of treatment information

  • 1,38000lei 1260.00 lei

     •             Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues - plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.

                 Analyzes the cost-benefit and cost-effectiveness of different vaccine options.

                 Helps you clearly visualize concepts and objective data through an abundance of tables and figures.

    New To This Edition:

                 Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine.

                 Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines.

                 Features a new chapter on maternal immunization.

                 Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

  • 1319.00 lei

    Tropical Infectious Diseases: Principles, Pathogens and Practice, by Drs. Richard L. Guerrant, David H. Walker, and Peter F. Weller, delivers the expert, encyclopedic guidance you need to overcome the toughest clinical challenges in diagnosing and treatin

  • 1,64200lei 1365.00 lei

    After thirty five years, Mandell, Douglas, and Bennett?s Principles and Practice of Infectious Diseases, 8th Edition is still the reference of choice for comprehensive, global guidance on diagnosing and treating the most challenging infectious diseases. Drs. John E. Bennett and Raphael Dolin along with new editorial team member Dr. Martin Blaser have meticulously updated this latest edition to save you time and to ensure you have the latest clinical and scientific knowledge at your fingertips. With new chapters, expanded and updated coverage, increased worldwide perspectives, and many new contributors, Mandell, Douglas, and Bennett?s Principles and Practice of Infectious Diseases, 8th Edition helps you identify and treat whatever infectious disease you see.
     
    "I highly recommend Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, together with the included ExpertConsult, the on-line version of the book that is a searchable source and is available to a variety of platforms. It is updated twice each year and is an excellent solution for health-care professionals to keep informed of the latest knowledge" Reviewed by Graefes Arch Clin Exp Ophthalmol, March 2015
     
    "..what an in depth textbook should be, a superb and vast, yet highly readable review of its topic." Reviewed by glycosmedia.com, Mar 2015
     
    "Principles and Practice of Infectious Diseases has many features and formats that make it a comprehensive, current, and clear source of information" Reviewed by Graefes Arch Clin Exp Ophthalmol, Feb 2015
     
    New to this edition
    Put the latest knowledge to work in your practice with new or completely revised chapters on influenza (new pandemic strains); new Middle East respiratory syndrome (MERS) virus; probiotics; antibiotics for resistant bacteria; antifungal drugs; new antivirals for hepatitis B and C; Clostridium difficile treatment; sepsis; advances in HIV prevention and treatment; viral gastroenteritis; Lyme disease; Helicobacter pylori; malaria; infections in immunocompromised hosts; immunization (new vaccines and new recommendations); and microbiome.
    Benefit from fresh perspectives and global insights from an expanded team of international contributors.
    Find and grasp the information you need easily and rapidly with newly added chapter summaries. These bulleted templates include diagnosis, therapy, and prevention and are designed as a quick summary of the chapter and to enhance relevancy in search and retrieval on Expert Consult.
    Stay current on Expert Consult with a thorough and regularly scheduled update program that ensures access to new developments in the field, advances in therapy, and timely information.
    Access the information you need easily and rapidly with new succinct chapter summaries that include diagnosis, therapy, and prevention.
    Experience clinical scenarios with vivid clarity through a richly illustrated, full-color format that includes 1500 photographs for enhanced visual guidance.

  • Human Emerging and Re-emerging Infections Set
    La comanda in aproximativ 4 saptamani
    1,59000lei 1450.00 lei

    Emerging and re-emerging pathogens pose several challenges to diagnosis, treatment, and public health surveillance, primarily because pathogen identification is a difficult and time-consuming process due to the “novel” nature of the agent. Proper identification requires a wide array of techniques, but the significance of these diagnostics is anticipated to increase with advances in newer molecular and nanobiotechnological interventions and health information technology. Human Emerging and Re-emerging Infections covers the epidemiology, pathogenesis, diagnostics, clinical features, and public health risks posed by new viral and microbial infections. The book includes detailed coverage on the molecular mechanisms of pathogenesis, development of various diagnostic tools, diagnostic assays and their limitations, key research priorities, and new technologies in infection diagnostics. Volume 1 addresses viral and parasitic infections, while volume 2 delves into bacterial and mycotic infections. Human Emerging and Re-emerging Infections is an invaluable resource for researchers in parasitologists, microbiology, Immunology, neurology and virology, as well as clinicians and students interested in understanding the current knowledge and future directions of infectious diseases.

  • 2,00500lei 1680.00 lei

    Description:

    For four decades, physicians and other healthcare providers have trusted Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases to provide expert guidance on the diagnosis and treatment of these complex disorders. The 9th Edition continues the tradition of excellence with newly expanded chapters, increased global coverage, and regular updates to keep you at the forefront of this vitally important field. Meticulously updated by Drs. John E. Bennett, Raphael Dolin, and Martin J. Blaser, this comprehensive, two-volume masterwork puts the latest information on challenging infectious diseases at your fingertips.

    Table Of Contents:

    I Basic Principles in the Diagnosis and Management of Infectious Diseases
    A MICROBIAL PATHOGENESIS
    1 A Molecular Perspective of Microbial Pathogenicity
    2 The Human Microbiome of Local Body Sites and Their Unique Biology
    3 Prebiotics, Probiotics, and Synbiotics
    B HOST DEFENSE MECHANISMS
    4 Innate (General or Nonspecific) Host Defense Mechanisms
    5 Adaptive Immunity: Antibodies and Immunodeficiencies
    6 Cell-Mediated Defense Against Infection
    7 Mucosal Immunity
    8 Granulocytic Phagocytes
    9 Complement and Deficiencies
    10 Human Genetics and Infection
    11 Nutrition, Immunity, and Infection
    12 Evaluation of the Patient With Suspected Immunodeficiency
    C EPIDEMIOLOGY OF INFECTIOUS DISEASE
    13 Applied Epidemiology for the Infectious Diseases Physician
    14 Emerging and Reemerging Infectious Disease Threats
    15 Bioterrorism: An Overview
    D CLINICAL MICROBIOLOGY
    16 The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation
    E ANTIINFECTIVE THERAPY
    17 Principles of Antiinfective Therapy
    18 Molecular Mechanisms of Antibiotic Resistance in Bacteria
    19 Pharmacokinetics and Pharmacodynamics of Antiinfective Agents
    20 Penicillins and ß-Lactamase Inhibitors
    21 Cephalosporins
    22 Ertapenem, Imipenem, Meropenem, Doripenem, and Aztreonam
    23 Antibiotic Allergy
    24 Fusidic Acid
    25 Aminoglycosides
    26 Tetracyclines, Glycylcyclines, and Chloramphenicol
    27 Rifamycins
    28 Metronidazole
    29 Macrolides and Clindamycin
    30 Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin)
    31 Daptomycin and Quinupristin-Dalfopristin
    32 Polymyxins (Polymyxin B and Colistin)
    33 Linezolid, Tedizolid, and Other Oxazolidinones
    34 Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole
    35 Quinolones
    36 Unique Antibacterial Agents
    37 Urinary Tract Agents: Nitrofurantoin, Fosfomycin, and Methenamine
    38 Topical Antibacterials
    39 Antimycobacterial Agents
    40A Antifungal Agents: Amphotericin B
    40B Antifungal Drugs: Azoles
    40C Antifungal Drugs: Echinocandins
    40D Antifungal Drugs: Flucytosine
    41 Antimalarial Drugs
    42 Drugs for Protozoal Infections Other Than Malaria
    43 Drugs for Helminths
    44 Antiviral Agents: General Principles
    45 Antiviral Drugs for Influenza and Other Respiratory Virus Infections
    46 Antivirals Against Herpesviruses
    47 Antiviral Drugs Against Hepatitis Viruses
    48 Miscellaneous Antiviral Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir, Pleconaril)
    49 Immunomodulators
    50 Hyperbaric Oxygen
    51 Antimicrobial Stewardship
    52 Designing and Interpreting Clinical Studies in Infectious Diseases
    53 Outpatient Parenteral Antimicrobial Therapy
    54 Tables of Antiinfective Agent Pharmacology
    II Major Clinical Syndromes
    A FEVER
    55 Temperature Regulation and the Pathogenesis of Fever
    56 Fever of Unknown Origin
    57 The Acutely Ill Patient With Fever and Rash
    B UPPER RESPIRATORY TRACT INFECTIONS
    58 The Common Cold
    59 Pharyngitis
    60 Acute Laryngitis
    61 Otitis Externa, Otitis Media, and Mastoiditis
    62 Sinusitis
    63 Epiglottitis
    64 Infections of the Oral Cavity, Neck, and Head
    C PLEUROPULMONARY AND BRONCHIAL INFECTIONS
    65 Acute Bronchitis
    66 Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    67 Acute Pneumonia
    68 Pleural Effusion and Empyema
    69 Bacterial Lung Abscess
    70 Chronic Pneumonia
    71 Cystic Fibrosis
    D URINARY TRACT INFECTIONS
    72 Urinary Tract Infections
    E SEPSIS
    73 Sepsis and Septic Shock
    F INTRAABDOMINAL INFECTIONS
    74 Peritonitis and Intraperitoneal Abscesses
    75 Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis)
    76 Pancreatic Infection
    77 Splenic Abscess
    78 Appendicitis
    79 Diverticulitis and Neutropenic Enterocolitis
    G CARDIOVASCULAR INFECTIONS
    80 Endocarditis and Intravascular Infections
    81 Prosthetic Valve Endocarditis
    82 Infections of Nonvalvular Cardiovascular Devices
    83 Prevention of Infective Endocarditis
    84 Myocarditis and Pericarditis
    85 Mediastinitis
    H CENTRAL NERVOUS SYSTEM INFECTIONS
    86 Approach to the Patient With Central Nervous System Infection
    87 Acute Meningitis
    88 Chronic Meningitis
    89 Encephalitis
    90 Brain Abscess
    91 Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis
    92 Cerebrospinal Fluid Shunt and Drain Infections
    I SKIN AND SOFT TISSUE INFECTIONS
    93 Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections
    94 Myositis and Myonecrosis
    95 Lymphadenitis and Lymphangitis
    J GASTROINTESTINAL INFECTIONS AND FOOD POISONING
    96 Syndromes of Enteric Infection
    97 Esophagitis
    98 Diarrhea With Little or No Fever
    99 Acute Dysentery Syndromes (Diarrhea With Fever)
    100 Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers
    101 Foodborne Disease
    102 Tropical Sprue and Environmental Enteric Dysfunction
    K BONE AND JOINT INFECTIONS
    103 Infectious Arthritis of Native Joints
    104 Osteomyelitis
    105 Orthopedic Implant-Associated Infections
    L DISEASES OF THE REPRODUCTIVE ORGANS AND SEXUALLY TRANSMITTED DISEASES
    106 Genital Skin and Mucous Membrane Lesions
    107 Urethritis
    108 Vulvovaginitis and Cervicitis
    109 Infections of the Female Pelvis
    110 Prostatitis, Epididymitis, and Orchitis
    M EYE INFECTIONS
    111 Introduction to Eye Infections
    112 Microbial Conjunctivitis
    113 Microbial Keratitis
    114 Endophthalmitis
    115 Infectious Causes of Uveitis
    116 Periocular Infections
    N HEPATITIS
    117 Viral Hepatitis
    O ACQUIRED IMMUNODEFICIENCY SYNDROME
    118 Global Perspectives on Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
    119 Epidemiology and Prevention of AIDS and HIV Infection, Including Preexposure Prophylaxis and HIV Vaccine Development
    120 Diagnosis of Human Immunodeficiency Virus Infection
    121 The Immunology of Human Immunodeficiency Virus Infection
    122 General Clinical Manifestations of Human Immunodeficiency Virus Infection (Including Acute Retroviral Syndrome and Oral, Cutaneous, Renal, Ocular, Metabolic, and Cardiac Diseases)
    123 Pulmonary Manifestations of Human Immunodeficiency Virus Infection
    124 Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of Human Immunodeficiency Virus Infection
    125 Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections
    126 Human Immunodeficiency Virus Infection in Women
    127 Pediatric Human Immunodeficiency Virus Infection
    128 Antiretroviral Therapy for Human Immunodeficiency Virus Infection
    129 Management of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
    P MISCELLANEOUS SYNDROMES
    130 Chronic Fatigue Syndrome (Systemic Exertion Intolerance Disease)
    III Infectious Diseases and Their Etiologic Agents
    A VIRAL DISEASES
    131 Biology of Viruses and Viral Diseases
    132 Orthopoxviruses Vaccinia (Smallpox Vaccine), Variola (Smallpox), Monkeypox, and Cowpox
    133 Other Poxviruses That Infect Humans: Parapoxviruses (Including Orf Virus), Molluscum Contagiosum, and Yatapoxviruses
    134 Introduction to Herpesviridae
    135 Herpes Simplex Virus
    136 Chickenpox and Herpes Zoster (Varicella-Zoster Virus)
    137 Cytomegalovirus
    138 Epstein-Barr Virus (Infectious Mononucleosis, Epstein-Barr Virus-Associated Malignant Diseases, and Other Diseases)
    139 Human Herpesvirus Types 6 and 7 (Exanthem Subitum)
    140 Kaposi Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)
    141 Herpes B Virus
    142 Adenoviruses
    143 Papillomaviruses
    144 JC, BK, and Other Polyomaviruses: Progressive Multifocal Leukoencephalopathy (PML)
    145 Hepatitis B Virus
    146 Hepatitis Delta Virus
    147 Human Parvoviruses, Including Parvovirus B19V and Human Bocaparvoviruses
    148 Orthoreoviruses and Orbiviruses
    149 Coltiviruses (Colorado Tick Fever Virus) and Seadornaviruses
    150 Rotaviruses
    151 Alphaviruses (Chikungunya, Eastern Equine Encephalitis)
    152 Rubella Virus (German Measles)
    153 Flaviviruses (Dengue, Yellow Fever, Japanese Encephalitis, West Nile Encephalitis, Usutu Encephalitis, St. Louis Encephalitis, Tick-Borne Encephalitis, Kyasanur Forest Disease, Alkhurma Hemorrhagic Fever, Zika)
    154 Hepatitis C
    155 Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)
    156 Parainfluenza Viruses
    157 Mumps Virus
    158 Respiratory Syncytial Virus
    159 Human Metapneumovirus
    160 Measles Virus (Rubeola)
    161 Zoonotic Paramyxoviruses: Nipah, Hendra, and Menangle Viruses
    162 Vesicular Stomatitis Virus and Related Vesiculoviruses (Chandipura Virus)
    163 Rabies (Rhabdoviruses)
    164 Marburg and Ebola Virus Hemorrhagic Fevers
    165 Influenza Viruses, Including Avian Influenza and Swine Influenza
    166 California Encephalitis, Hantavirus Pulmonary Syndrome, Hantavirus Hemorrhagic Fever With Renal Syndrome, and Bunyavirus Hemorrhagic Fevers
    167 Lymphocytic Choriomeningitis Virus, Lassa Virus, and the South American Hemorrhagic Fevers (Arenaviruses)
    168 Human T-Cell Leukemia Viruses (HTLV-1, HTLV-2)
    169 Human Immunodeficiency Viruses
    170 Introduction to the Human Enteroviruses and Parechoviruses
    171 Poliovirus
    172 Coxsackieviruses, Echoviruses, and Numbered Enteroviruses (EV-A71, EVD-68, EVD-70)
    173 Parechoviruses
    174 Hepatitis A Virus
    175 Rhinovirus
    176 Noroviruses and Sapoviruses (Caliciviruses)
    177 Astroviruses and Picobirnaviruses
    178 Hepatitis E Virus
    B PRION DISEASES
    179 Prions and Prion Disease of the Central Nervous System (Transmissible Neurodegenerative Diseases)
    C CHLAMYDIAL DISEASES
    180 Chlamydia trachomatis (Trachoma and Urogenital Infections)
    181 Psittacosis (Due to Chlamydia psittaci)
    182 Chlamydia pneumoniae
    D MYCOPLASMA DISEASES
    183 Mycoplasma pneumoniae and Atypical Pneumonia
    184 Genital Mycoplasmas: Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma Species
    E RICKETTSIOSES, EHRLICHIOSES, AND ANAPLASMOSES
    185 Introduction to Rickettsioses, Ehrlichioses, and Anaplasmoses
    186 Rickettsia rickettsii and Other Spotted Fever Group Rickettsiae (Rocky Mountain Spotted Fever and Other Spotted Fevers)
    187 Rickettsia akari (Rickettsialpox)
    188 Coxiella burnetii (Q Fever)
    189 Rickettsia prowazekii (Epidemic or Louse-Borne Typhus)
    190 Rickettsia typhi (Murine Typhus)
    191 Orientia tsutsugamushi (Scrub Typhus)
    192 Ehrlichia chaffeensis (Human Monocytotropic Ehrlichiosis), Anaplasma phagocytophilum (Human Granulocytotropic Anaplasmosis), and Other Anaplasmataceae
    F BACTERIAL DISEASES
    193 Introduction to Bacteria and Bacterial Diseases
    194 Staphylococcus aureus (Including Staphylococcal Toxic Shock Syndrome)
    195 Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci
    196 Classification of Streptococci
    197 Streptococcus pyogenes
    198 Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and Glomerulonephritis
    199 Streptococcus pneumoniae
    200 Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species
    201 Streptococcus agalactiae (Group B Streptococci)
    202 Viridans Streptococci, Nutritionally Variant Streptococci, and Groups C and G Streptococci
    203 Streptococcus anginosus Group
    204 Corynebacterium diphtheriae (Diphtheria)
    205 Other Coryneform Bacteria, Arcanobacterium haemolyticum, and Rhodococci
    206 Listeria monocytogenes
    207 Bacillus anthracis (Anthrax)
    208 Bacillus Species and Related Genera Other Than Bacillus anthracis
    209 Erysipelothrix Rhusiopathiae
    210 Whipple Disease
    211 Neisseria meningitidis
    212 Neisseria gonorrhoeae (Gonorrhea)
    213 Moraxella catarrhalis, Kingella, and Other Gram-Negative Cocci
    214 Vibrio cholerae
    215 Other Pathogenic Vibrios
    216 Campylobacter jejuni and Related Species
    217 Helicobacter pylori and Other Gastric Helicobacter Species
    218 Enterobacteriaceae
    219 Pseudomonas aeruginosa and Other Pseudomonas Species
    220 Stenotrophomonas maltophilia and Burkholderia cepacia Complex
    221 Burkholderia pseudomallei and Burkholderia mallei: Melioidosis and Glanders
    222 Acinetobacter Species
    223 Salmonella Species
    224 Bacillary Dysentery: Shigella and Enteroinvasive Escherichia coli
    225 Haemophilus Species, Including H. influenzae and H. ducreyi (Chancroid)
    226 Brucellosis (Brucella Species)
    227 Francisella tularensis (Tularemia)
    228 Pasteurella Species
    229A Plague (Yersinia pestis)
    229B Yersinia enterocolitica and Yersinia pseudotuberculosis
    230 Bordetella pertussis
    231 Rat-Bite Fever: Streptobacillus moniliformis and Spirillum minus
    232 Legionnaires’ Disease and Pontiac Fever
    233 Capnocytophaga
    234 Bartonella, Including Cat-Scratch Disease
    235 Klebsiella granulomatis (Donovanosis, Granuloma Inguinale)
    236 Other Gram-Negative and Gram-Variable Bacilli
    237 Syphilis (Treponema pallidum)
    238 Endemic Treponematoses
    239 Leptospira Species (Leptospirosis)
    240 Relapsing Fever Caused by Borrelia Species
    241 Lyme Disease (Lyme Borreliosis) Due to Borrelia burgdorferi
    242 Anaerobic Infections: General Concepts
    243 Clostridioides difficile (Formerly Clostridium difficile) Infection
    244 Tetanus (Clostridium tetani)
    245 Botulism (Clostridium botulinum)
    246 Diseases Caused by Clostridium
    247 Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli)
    248 Anaerobic Cocci and Anaerobic Gram-Positive Nonsporulating Bacilli
    249 Mycobacterium tuberculosis
    250 Leprosy (Mycobacterium leprae)
    251 Mycobacterium avium Complex
    252 Infections Caused by Nontuberculous Mycobacteria Other Than Mycobacterium avium Complex
    253 Nocardia Species
    254 Agents of Actinomycosis
    G MYCOSES
    255 Introduction to Mycoses
    256 Candida Species
    257 Aspergillus Species
    258 Agents of Mucormycosis and Entomophthoramycosis
    259 Sporothrix schenckii
    260 Agents of Chromoblastomycosis
    261 Agents of Mycetoma
    262 Cryptococcosis (Cryptococcus neoformans and Cryptococcus gattii)
    263 Histoplasma capsulatum (Histoplasmosis)
    264 Blastomycosis
    265 Coccidioidomycosis (Coccidioides Species)
    266 Dermatophytosis (Ringworm) and Other Superficial Mycoses
    267 Paracoccidioidomycosis
    268 Uncommon Fungi and Related Species
    269 Pneumocystis Species
    270 Microsporidiosis
    H PROTOZOAL DISEASES
    271 Introduction to Protozoal Diseases
    272 Entamoeba Species, Including Amebic Colitis and Liver Abscess
    273 Free-Living Amebae
    274 Malaria (Plasmodium Species)
    275 Leishmania Species: Visceral (Kala-Azar), Cutaneous, and Mucosal Leishmaniasis
    276 Trypanosoma Species (American Trypanosomiasis, Chagas Disease): Biology of Trypanosomes
    277 Agents of African Trypanosomiasis (Sleeping Sickness)
    278 Toxoplasma gondii
    279 Giardia lamblia
    280 Trichomonas vaginalis
    281 Babesia Species
    282 Cryptosporidiosis (Cryptosporidium Species)
    283 Cyclospora cayetanensis, Cystoisospora belli, Sarcocystis Species, Balantidium coli, and Blastocystis Species
    I DISEASES DUE TO TOXIC ALGAE
    284 Human Illness Associated With Harmful Algal Blooms
    J DISEASES DUE TO HELMINTHS
    285 Introduction to Helminth Infections
    286 Intestinal Nematodes (Roundworms)
    287 Tissue Nematodes, Including Trichinellosis, Dracunculiasis, Filariasis, Loiasis, and Onchocerciasis
    288 Trematodes (Schistosomes and Liver, Intestinal, and Lung Flukes)
    289 Tapeworms (Cestodes)
    290 Visceral Larva Migrans and Other Uncommon Helminth Infections
    K ECTOPARASITIC DISEASES
    291 Introduction to Ectoparasitic Diseases
    292 Lice (Pediculosis)
    293 Scabies
    294 Myiasis and Tungiasis
    295 Mites, Including Chiggers
    296 Ticks, Including Tick Paralysis
    L DISEASES OF UNKNOWN ETIOLOGY
    297 Kawasaki Disease
    IV Special Problems
    A NOSOCOMIAL INFECTIONS
    298 Infection Prevention and Control in the Health Care Setting
    299 Disinfection, Sterilization, and Control of Hospital Waste
    300 Infections Caused by Percutaneous Intravascular Devices
    301 Nosocomial Pneumonia
    302 Health Care-Associated Urinary Tract Infections
    303 Health Care-Acquired Hepatitis
    304 Transfusion- and Transplantation-Transmitted Infections
    B INFECTIONS IN SPECIAL HOSTS
    305 Infections in the Immunocompromised Host: General Principles
    306 Prophylaxis and Empirical Therapy of Infection in Cancer Patients
    307 Infections in Recipients of Hematopoietic Stem Cell Transplants
    308 Infections in Solid-Organ Transplant Recipients
    309 Infections in Patients With Spinal Cord Injury
    310 nfections in Older Adults
    311 Infections in Asplenic Patients
    312 Infections in Injection Drug Users
    313 Surgical Site Infections and Antimicrobial Prophylaxis
    C SURGICAL- AND TRAUMA-RELATED INFECTIONS
    314 Burns
    315 Bites
    D IMMUNIZATION
    316 Immunization
    E ZOONOSES
    317 Zoonoses
    F PROTECTION OF TRAVELERS
    318 Protection of Travelers
    319 Infections in Returning Travelers

Scroll